David P. Joyce sold SPDR Series Trust SPDR S&P Biotech ETF (XBI) [ST] (XBI)
David P. Joyce (R-OH), a U.S. Representative, has disclosed 2 trades in SPDR Series Trust SPDR S&P Biotech ETF (XBI) [ST] (XBI) since 2017, 1 purchase and 1 sale, worth an estimated $41K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: David P. Joyce sold $15,001 - $50,000 of SPDR Series Trust SPDR S&P Biotech ETF (XBI) [ST] (XBI) on June 30, 2023. Since that trade, XBI is up +87.84% against the S&P 500 up +75.60%, an outperformance of +12.23%.
Across these filings, David P. Joyce has been a balanced trader of XBI (a buy-to-sell ratio of 1.00). Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
David P. Joyce's XBI trades vs the price
XBI is up +87.84% since David P. Joyce sold on June 30, 2023, versus +75.60% for the S&P 500.
Performance since this trade
All David P. Joyce XBI trades
David P. Joyce & XBI trading FAQ
Is it legal for David P. Joyce to trade SPDR Series Trust SPDR S&P Biotech ETF (XBI) [ST] (XBI) stock?
Yes. Members of Congress are allowed to trade individual stocks, including SPDR Series Trust SPDR S&P Biotech ETF (XBI) [ST] (XBI), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did David P. Joyce sell XBI?
David P. Joyce disclosed a sale of $15,001 - $50,000 of SPDR Series Trust SPDR S&P Biotech ETF (XBI) [ST] (XBI) on June 30, 2023, according to public STOCK Act filings.
How has XBI performed since David P. Joyce's trade?
Since David P. Joyce sold XBI on June 30, 2023, the stock is up +87.84%, versus +75.60% for the S&P 500 over the same period, an outperformance of +12.23%.
How many times has David P. Joyce traded XBI?
David P. Joyce has disclosed 2 XBI trades since 2017 (1 purchase and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional XBI trades?
Quantellect tracks every disclosed congressional trade in SPDR Series Trust SPDR S&P Biotech ETF (XBI) [ST] (XBI) on the SPDR Series Trust SPDR S&P Biotech ETF (XBI) [ST] congressional trading page, which aggregates filings across all members of Congress.
David P. Joyce's XBI tradesAll congressional filings for SPDR Series Trust SPDR S&P Biotech ETF (XBI) [ST]David P. Joyce's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.